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http:WHAT THIS PAPER ADDS
This study was designed to evaluate the outcome of patients who underwent endovenous microwave ablation
(EMA). This new endovenous therapy technique was compared with high ligation and stripping. Our results
demonstrate that the EMA technique showed favourable short- and medium-term clinical outcomes. This
technique showed similar results to other endovenous techniques, and is an effective and technically feasible
new technique for the treatment of varicose veins.Objective: To evaluate the efﬁcacy of endovenous microwave ablation (EMA) in treatment of varicose veins
(VVS).
Methods: The patients were randomly divided into EMA and high ligation and stripping (HLS) groups. Clinical
outcomes and complications were assessed at 1, 3, 6, 12, and 24 months after surgery, and the effect on quality
of life was also assessed using the Aberdeen Varicose Vein Questionnaire (AVVQ) and Venous Clinical Severity
Score (VCSS) respectively.
Results: EMA occluded VVS completely, with a shorter operative time, less bleeding and smaller incisions than
the HLS procedure. In the EMA group, skin burns were found on 11 limbs (10.2%); sensory alteration and
ecchymosis were less; and the recurrence rate of VVS was relatively lower compared with the HLS group. Both
groups had signiﬁcant improvement in VCSS and disease-speciﬁc quality of life (AVVQ) postoperatively. There was
no signiﬁcant difference in AVVQ and VCSS scores between the groups.
Conclusion: EMA is an effective new technique for the treatment of VVS, and had a more satisfactory clinical
outcome than HLS in the short term.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Varicose veins (VVS) is a common disease in adults, and VVS
without skin changes are present in about 20% of the
population, while active ulcers are found in 0.5%.1 The
traditional surgical treatment of VVS is high ligation of the
great saphenous vein (GSV), axial stripping and phlebec-
tomy, but the postoperative clinical recurrence is as high as
60%.2 Recently, minimally invasive techniques, such as
endovenous laser ablation (EVLA) and radiofrequency
ablation (RFA), have become widely used for the treatment
of VVS.3e7 Several reports have shown that endovenous
techniques are as effective as traditional procedures.5e7
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//dx.doi.org/10.1016/j.ejvs.2013.07.004microwave ablation (EMA) for the treatment of VVS. We
used the intracavity microwave coagulation system to treat
the VVS in this study.
EMA for the treatment of VVS differs from the other
endovenous methods, and no speciﬁc dose regime has been
established for this system. Thus, it is unclear if EMA is more
or less effective than conventional surgery, or whether it
has any additional beneﬁts. In this study, we compared the
clinical outcome of high ligation and stripping (HLS) with
EMA. Postoperative quality of life (QoL) analysis was
assessed using the Aberdeen Varicose Vein Questionnaire
(AVVQ) and Venous Clinical Severity Score (VCSS).8,9
PATIENTS AND METHODS
Patients
The patients with VVS were enrolled between May 2007
and June 2009. Suitable patients were assessed, and the
selection of patients was considered (Fig. 1). All patients
were randomized to undergo either EMA with high-tie or
conventional surgery (via random digits table).
Figure 1. CONSORT chart showing the ﬂow of patients through the trial of surgery (high ligation and stripping) versus endovenous mi-
crowave ablation (EMA).
Table 1. Demographics and CEAP classiﬁcation in the endovenous
microwave ablation (EMA) and high ligation and stripping (HLS)
groups.
EMA HLS p
Patients/limbs 100/108 88/98
Age (y) 59 (43e69) 58 (46e70) NS
Gender (F/M) 51/49 48/40 NS
Course of disease (y) 10 (2e40) 10 (3e33) NS
No. of perforators NS
Below the knee 195 168
Above the knee 71 64
Note. Values in parentheses indicate the range. y ¼ year;
F ¼ female; M ¼ male; NS ¼ not statistically signiﬁcant.
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C3eC6), sapheno-femoral junction (SFJ) incompetence, GSV
reﬂux from the groin to below the knee (retrograde ﬂow
lasting longer than 0.5 s on duplex scanning), and reﬂux of
deep vein not going beyond the knee.
Exclusion criteria included a history of venous surgery,
suspected or proven deep venous thrombosis, reﬂux of
deep veins to distal limb, duplication of GSV, and patients’
refusal to participate in the trial.
The patients were examined by duplex ultrasound (ATL
3500 HDI; ATL Ultrasound, Bothell, WA, USA), and the
number of incompetent perforators and the presence of
deep venous reﬂux were documented (Table 1). Before
surgery, the sites of varices, incompetent perforators, and
the SFJ were marked on the skin.
This trial was approved by the local ethics committee and
institutional review board, and all patients provided written
informed consent.
Treatment
In both groups, all treatments were performed under
epidural anaesthesia by two experienced surgeons.
HLS group. Conventional surgical procedures were carried
out through a 3e4 cm incision in the groin. The trunk of
GSV and the tributaries were ligated and divided. The GSV
was removed using a pin-stripper, and all varices and
incompetent perforators were removed by phlebectomy.
VVS underneath an ulcer were also removed by stab phle-
bectomies performed through normal skin at an angle.EMA group. First, the SFJ was ligated in the same way as in
the HLS group. Then, the microwave treating wire (Micro-
wave Intracavity Coagulation System; Shanghai Medical
Electronics, Shanghai, China) (Fig. 2; length is 150 cm from
proximal to distal) was inserted into the GSV until it reached
the medial aspect of ankle. This was guided by a light that
illuminated the tip of the wire. Then, GSV was ablated using
pulse mode at 20e30 W. The treating wire was withdrawn
at 2e4 mm/s, with the ablation time lasting 2 s (energy
delivery to the GSV was estimated at around 80 J/cm); the
treatment parameters were based on a previous report and
our own experience.10 Tumescence was used in all patients
with 0.9% saline containing 20 mL 2% lidocaine with 1:
200,000 adrenaline and 20 mL 0.5% levobupivacaine in 1 L
0.9% saline. Total local anaesthetic did not exceed the rec-
ommended maximum safe dose per patient. When the
Figure 2. Diagram of the microwave ablation system. The work station generates microwave energy at 2,450 MHz, and the energy current
is transmitted through transducer catheter (deep blue), which connects with the microwave wire (light blue). The laser light wire connects
with the root of the great saphenous vein (GSV)-treating wire (A), the heating electrode (arrow), and the laser light (dashed arrow), located
at the tip of wire (B). There is no laser light in the short wire (C, D), which connects with the transducer catheter. Then, GSV and tributary
varices were ablated using the treating wire. The temperature of the microwave heating effect was about 90e100 C in this study.
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method (because of the tortuosity of the veins; 20 limbs,
16.4%), the treating wire was inserted into the GSV from
the ankle puncture and was ablated from groin to ankle
with the main trunk (the tip of the wire was placed 0.5e
1 cm away from the ligation point of GSV to avoid un-
wanted damage). All superﬁcial VVS and perforators were
ablated successfully using a short wire (power was 10e
15 W and the withdrawal speed was 2e4 mm/s, with the
ablation time lasting 1 s), this short microwave wire could
be inserted into varices 2e12 cm. Very large varices were
excised through a small incision.
In the EMA group, VVS under ulcers were punctured
through normal skin around the ulcer and ablated. The
perforators were ablated under the guidance of duplex ul-
trasound in the EMA group (Fig. 3A), which is different from
that of GSV and superﬁcial VVS.Figure 3. Treating the tributary veins under the guidance of ultrasoun
veins (black arrow), and then (B) ablating the veins, we could ﬁnd the t
the ultrasound image.After surgery, the limbs were wrapped with sterile absor-
bent bandages and covered with a cohesive compression
bandage for 48 h; thereafter, patients were instructed to wear
a medical compression stocking (25 mmHg, ankle) during the
day for at least 6 weeks. Ulcers were covered with sterile
gauze, which was changed once every 3 days.Follow-up
Criteria for technical success were closed or absent GSV
with lack of ﬂow. A re-canalized GSV or treatment failure
was deﬁned as an open segment of the treated vein
segment of >10 cm in length. All patients were followed as
outpatients up at 1, 3, 6, 12, and 24 months after surgery.
The operation time, number of incisions, intraoperative
blood loss (determined by the swabs weighed pre-
and postoperatively), and recurrence of varicosities wered. (A) By inserting the short wire (white arrow) into the tributary
hrombotic change around the tip of the treat wire on (long arrow)
Figure 4. The ultrasound image of the great saphenous vein (GSV) perioperatively. (A) Two-dimensional image of GSV before treatment,
and detection of treated veins at 1 month (B) and 6 months postoperatively (C).
476 L. Yang et al.recorded, as well as any complications, were recorded. The
criteria for assessment were as follows.
1. Ecchymosis was conﬁrmed 72 h after operation when
the lividity and congestion area was >1 cm2 in the
affected limbs.
2. Skin burns were identiﬁed 72 h after operation when
the skin was red and oedematous according to the
criteria for burns.
3. Recurrence was deﬁned by both duplex ultrasound and
the clinical examination. A varicose vein that had not
been observed before or previously been marked by the
patient on the AVVQ form was considered to be a
recurrent varicose vein (owing to neo-vascularization or
dilation of pre-existing veins).7,11
4. Sensory impairment (numbness) that occurred around
incisions was recorded based on the patient’s history
and physical examination.
QoL assessment
The diseased relation effect on QoL was determined using
the AVVQ (Chinese version), which assessed the speciﬁc
effect on QoL and was scored from 0 (no effect of VVS on
QoL) to a theoretical maximum of 100.8 The VCSS (Chinese
version) was also completed (for the VCSS, 0 represents no
signiﬁcant venous disease and 30 is the maximum score),
which is a valid sensitive and responsive measure of the
severity of VVS.9Statistical analysis
All data were analysed using SPSS v. 11.0 (SPSS, Chicago, IL,
USA) and p <.05 was considered statistically signiﬁcant.
Categorical data were analysed using a chi-square test or,
continuous data were ﬁrst tested for normality. Normally
distributed data were presented as mean (SD), and hy-
pothesis signiﬁcance testing was performed with paired and
unpaired t tests. If the data were not normally distributed,
median (interquartile range) values were presented, ana-
lysed using the ManneWhitney U test for unrelated sam-
ples and the Wilcoxon signed rank test for paired data.RESULTS
Clinical data (Table 1)
A total of 200 patients was randomized, as intended (Fig. 1).EMA group. The EMA group consisted of 100 patients (108
limbs) with a median age of 59 years (range: 43e69 years),
including 49 men (54 limbs) and 51 women (54 limbs). The
median duration of disease prior to treatment was 10 years
(range: 2e40 years). Moreover, 28 affected limbs had an
ulcer (CEAP classiﬁcation: C3, 27 limbs; C4, 33 limbs; C5, 20
limbs; C6, 28 limbs), with an ulcer of more than 2 cm2 in 16
limbs. There were 195 perforator veins below the knee, and
71 perforator veins above the knee.
HLS group. In the HLS group 12 patients did not undergo
surgery; thus, there were 88 patients (98 limbs) with a
median age of 58 years (range: 46e70 years), including 40
men (45 limbs) and 48 women (53 limbs). The median
duration of disease was 10 years (range: 3e33 years).
Moreover, 23 affected limbs had an ulcer (CEAP classiﬁca-
tion: C3, 30 limbs; C4, 25 limbs; C5: 20 limbs; C6: 23 limbs),
with an ulcer of more than 2 cm2 in 14 limbs. There were
168 perforator veins below the knee, and 64 perforator
veins above the knee.
Clinical outcomes
The demographics and CEAP classiﬁcation were comparable
between the two groups (Table 1). In both groups, treat-
ment was successful, and most participants completed
follow-up as outpatients. In the EMA group, two patients
(two limbs) were lost to follow-up at 12 months and ﬁve
patients (eight limbs) at 24 months, respectively. Three
patients (four limbs) and seven patients (nine limbs) were
lost to follow-up at 12 and 24 months in HLS group,
respectively.
The mean operation time was signiﬁcantly longer in the
HLS group than in the EMA group (99  31 min vs.
78  25 min, p < .01), and more operative incisions were
needed to complete the procedure in the patients in the
HLS group than those in the EMA group (4  1.2 vs.
1.5  0.7, p < .01). Compared with patients in the HLS
group, those in the EMA group had less intraoperative
bleeding (116  42 mL vs. 28  9.8 mL, p < .01). Moreover,
the postoperative healing time of the ulcer was faster in
patients in the EMA group than in those in HLS group
(45  9.1 days vs. 74  16 days, p < .01).
Ultrasound outcomes were assessed using duplex ultra-
sound 1, 3, 6 and 12 months postoperatively. In the EMA
group, complete occlusion was noted in 116/122 limbs
(95.1%) after 1 month. All treated veins showed shrinkage
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detected at the tip of the wire (Fig. 3B). The hyperechoic
signal and organized thrombosis signals were detected in
ablated vein lumen by duplex ultrasound (Fig. 3B). The
ablated veins developed ﬁbrosis and then occluded
completely at 6 and 12 months postoperatively (Fig. 4), with
the occlusion rates being 99% (121/122) and 97% (116/
120), respectively. Few patients showed small re-
canalization in superﬁcial veins, and the incidence rates
were 1.6%, 0.9%, and 3.3% at 1, 6, and 12 months,
respectively. In the HLS group, no GSV or perforator veins
were detected in the treated area.Complications
No deep vein thrombosis or wound infection developed
after surgery in either treatment group (Table 2). The inci-
dence of ecchymosis was higher in the HLS group than in
the EMA group (31.6% vs. 14.8%, p ¼ .004). In contrast, skin
burns occurred on 11 limbs in the EMA group (10.2%),
which was the main adverse effect of EMA. These skin burns
usually developed at the puncture sites. In the HLS group,
the incidence of sensory impairment was higher than in the
EMA group 1 month postoperatively (28.6% vs. 15.7%,
p ¼ .03), but in most patients symptoms of altered sensa-
tion had resolved by 6 months after surgery. Sensory
impairment was found in seven limbs in the EMA group and
16 limbs in the HLS group (6.5% vs. 16.3%, p < .001) at the
6-month follow-up examination; most sensory impairment
occurred along the GSV and the ablation sites below the
knee.Recurrence
Recurrence was the main long-term complication, and EMA
had a lower recurrence rate than HLS after 6 months (2.8%
vs. 10.2%, p ¼ .03). The recurrence rates increased gradu-
ally from 6 months to the 2-year follow-up. Recurrence was
found in 14 and 24 limbs in the EMA and HLS groups,
respectively (14.3% vs. 28.2%, p ¼ .02). In the EMA group,
six limbs were found with recurrence of neovascularization
in the superﬁcial veins of the thigh. Recurrence of incom-
petent tributary veins below the knee was found in eight
limbs. In the HLS group, neovascularization occurring at theTable 2. Incidence of complications in the endovenous microwave
ablation (EMA) and high ligation and stripping (HLS) groups.
EMA HLS p
Ecchymosis (%) 16 (14.8) 31 (31.6) .004
Sensory impairment (%)
1 mo 17 (15.7) 28 (28.6) .03
6 mo 7 (6.5) 16 (16.3) <.001
Skin burns (%) 11 (10.2) 0 (0) .001
Recurrence (%)
6 mo 3 (2.8) 10 (10.2) .03
2 y 14 (14.3) 24 (28.2) .02
Others 0 0
Note. Values in parentheses indicate the percentage.
mo ¼ months; y ¼ years.treated sites was found in 14 limbs, and recurrence at new
sites was found in 10 limbs, which might correlate, among
other reasons, with incompetent veins.QoL assessment
Both groups had the same decrease (improvement) in
AVVQ (Fig. 5A) and VCSS (Fig. 5B) scores after operation
(p < .001), there was no signiﬁcant difference in AVVQ and
VCSS scores between the groups at any time point
(p > .05). The improvement in AVVQ and VCSS scores was
still present after 2 years (Fig. 5).DISCUSSION
HLS is a conventional method for treatment of VVS;
however, this procedure is associated with frequent
recurrence (60%), complications, and longer operation
time.12,13 This study demonstrated that EMA resulted in a
shorter operation time, fewer incisions, and less intra-
operative bleeding than HLS. These ﬁndings suggest that
EMA outstrips the traditional HLS in that it could achieve a
favourable clinical outcome and success rate. The present
study conﬁrmed that both surgery and EMA are highly
efﬁcacious, and both result in signiﬁcant improvements in
the objective severity of venous disease, with lower VCSS
values and decreased AVVQ scores postoperatively. There
was no signiﬁcant difference in clinical efﬁcacy between
the two groups with regard to QoL at the same time point
after treatment.
In this study, the clinical success of ablation is deﬁned
according to that used in earlier publications.14 EMA, which
was combined with SFJ ligation, showed a high occlusion
rate, similar to that of the EVLA and RFA procedures.15,16
The difference in occlusion rate might correlate with the
mechanisms of the device in which the efﬁcacy of RFA was
obtained by heat-induced venous spasm due to venous wall
shrinkage. EMA induces direct and indirect thermal damage
to the vessel walls by heating blood components. In this
study, the EMA wire used was modiﬁed from the microwave
probe used for upper gastrointestinal ablation,10 which was
speciﬁcally manufactured for the treatment of VVS (Fig. 1).
The VNUS Closure system used the speciﬁcally designed
catheter and electrode, but most Chinese patients cannot
afford the expensive treatment fee. Our results showed that
the clinical outcomes and QoL of EMA were similar to those
of the RFA and EVLA techniques.17,18
In China, most patients with VVS present when their
conditions are at an advanced stage and accompanied by
limb ulcers. Traditional HLS is of limited value for the
treatment of venous ulcers unless reﬂux adjacent to the
ulcer is also treated. In our study, the short wire could be
passed into perforators and tributaries 2e12 cm, and could
puncture the varices and perforators from different di-
rections; thus, the varices could be ablated completely. The
EMA procedure could effectively occlude the tortuous
varices around the ulcers, and improve the pathological
state of ulcers, and then promoting the healing of ulcers.19
Figure 5. Aberdeen Varicose Vein Questionnaire (AVVQ) (A) and Venous Clinical Severity Score (VCSS) (B) score in patients treated with
endovenous microwave ablation (EMA) and high ligation and stripping (HLS). For improvement over time p <.001. There was no signiﬁcant
difference between groups at the same time point. Note. Error bars indicate mean  SD. mo ¼ months after operation.
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event following EMA and were presumably the result of
either energy levels that were too high or slow withdrawal
of the wire. According to our results and a previous
report,10 the energy level used in EMA procedure was safe
and effective. The temperature of microwave ablation (90e
100 C)20 was markedly lower than that used for EVLA
(800 C).4 Previous reports have suggested that microwave
ablation was relatively safe in terms of thermal effect
compared with RFA and EVLA.20,21 Inﬁltration of adequate
volumes of tumescence are important in preventing skin
burns, and they have become less common as experience
has increased at our centre.
However, the heat conduction of the microwave might
lead to skin burns when using EMA; thus, the tumescent
ﬂuid technique was recommended for patients, which
protected the skin from the thermal damage. As experience
of using EMA at our centre has increased, skin burns are no
longer common at our clinic. Thermal and physical damage
to the saphenous nerve can result in the sensory impair-
ment of limbs, which is a major adverse effect of HLS (7e
40%).20 Most sensory impairment occurred along the GSV
and at ablated sites below the knee, which might correlate
with temporary damage of the branches of the saphenous
nerve. Compared with HLS, EMA showed lower incidences
of sensory impairment at 1 and 6 months after surgery.
These patients recovered after 3e6 months without treat-
ment. Few patients who complain about sensory impair-
ment should be treated with physical and medicine therapy.
Ecchymosis is often caused by perforation of veins by the
EMA wire or by surgical trauma during HLS. In addition,
overly tight elastic bandages might also result in ecchymosis.
In our study, the incidence of ecchymosis was higher in the
HLS group than in EMA group. Proper compression with an
elastic bandage could minimize the ecchymosis, and most
patients may recover within 2 weeks without further
treatment. Other adverse effects, such as deep venous
thrombosis, and infection of ulcers and wound infection,
were not observed in our series. Clinically, we believed
that the GSV should be ligated ﬁrst and then ablated;
this procedure could avoid the damage of deep vein by
ablation and thrombosis extension into the femoral vein(one patient developed a deep vein thrombosis due to
thermal damage of a deep vein during our early experience).
The main adverse effect was recurrence after surgery,
which was associated with many factors.22 In our study,
recurrent varices occurred in the thigh and below the knee,
which may have been the result of neovascularization, po-
tential incompetent tributaries veins, and/or other sites of
reﬂux. HLS could not remove these potential perforator
veins and the small varices completely, but EMA could
ablate these veins effectively, and may have contributed to
the lower frequency of recurrence. When EMA is combined
with high ligation, recanalization could be less common,
although we have not examined this hypothesis in our
study. While there is some evidence that high ligation in
combination with another endovenous procedures could
improve outcomes,23,24 it is likely that neovascularisation
will be more common. Thus, most studies rely on EVLA or
RFA alone to treat GSV reﬂux. In order to examine our
hypothesis further, a randomized trial of EMA with or
without high ligation is required. There were three types of
recurrence in the groin after SFJ ligation; however, the
clinical relevance depended on the reconnection type, with
single lumen direct connection to the common femoral vein
being, by far, the most likely to be associated with a need
for further treatment;2 however, most of the neo-
vascularization had no evidence of clinical recurrence.25
Some data have suggested that preservation of groin trib-
utaries during endovenous technique avoids stimulating
angiogenesis.26
In conclusion, this study indicates that EMA with high
ligation provides a satisfactory outcome for patients with
VVS and GSV reﬂux. To examine its efﬁcacy further a trial
with or without high ligation should precede a larger,
multicentre study.
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